Neuroinflammatory Biomarkers in Cerebrospinal Fluid From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroinflammatory Biomarkers in Cerebrospinal Fluid From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
Authors
Keywords
Biomarkers, Cerebrospinal fluid, Depression, Neuroimmunology, Neuroinflammation
Journal
BIOLOGICAL PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-04-10
DOI
10.1016/j.biopsych.2022.04.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol
- (2022) Nina Vindegaard Sørensen et al. BMC Psychiatry
- Inflammatory Markers in Depression: a Meta-Analysis of Mean Differences and Variability in 5,166 Patients and 5,083 Controls
- (2020) Emanuele F. Osimo et al. BRAIN BEHAVIOR AND IMMUNITY
- Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia
- (2020) Wataru Omori et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Correction: Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
- (2020) Golam M. Khandaker et al. MOLECULAR PSYCHIATRY
- Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
- (2019) Golam M. Khandaker et al. MOLECULAR PSYCHIATRY
- Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia
- (2019) Toshiyuki Mizui et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Blood-brain barrier regulation in psychiatric disorders
- (2018) John Kealy et al. NEUROSCIENCE LETTERS
- Depression
- (2018) Gin S Malhi et al. LANCET
- Animal inflammation-based models of depression and their application to drug discovery
- (2017) Li Ma et al. Expert Opinion on Drug Discovery
- A Systematic Review of the Clinimetric Properties of the 6-Item Version of the Hamilton Depression Rating Scale (HAM-D6)
- (2017) N. Timmerby et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes
- (2016) Dominique Endres et al. JOURNAL OF AFFECTIVE DISORDERS
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- The Blood–Brain Barrier
- (2015) Richard Daneman et al. Cold Spring Harbor Perspectives in Biology
- Increased cerebrospinal fluid fibrinogen in major depressive disorder
- (2015) Kotaro Hattori et al. Scientific Reports
- Cross-national epidemiology of DSM-IV major depressive episode
- (2011) Evelyn Bromet et al. BMC Medicine
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
- (2011) M. Herdman et al. QUALITY OF LIFE RESEARCH
- Glial pathology is modified by age in mood disorders — A systematic meta-analysis of serum S100B in vivo studies
- (2010) Matthias L. Schroeter et al. JOURNAL OF AFFECTIVE DISORDERS
- Validation of Serum Markers for Blood-Brain Barrier Disruption in Traumatic Brain Injury
- (2009) Brian J. Blyth et al. JOURNAL OF NEUROTRAUMA
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Neurological abnormalities and cognitive ability in first-episode psychosis
- (2008) Paola Dazzan et al. BRITISH JOURNAL OF PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started